Health-care companies rose amid deal activity.
Eli Lilly continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker's blood-cancer portfolio.
India's Sun Pharmaceutical Industries has agreed to acquire the U.S.-listed healthcare company Organon in a deal valuing the company at $11.75 billion, positioning the Indian drugmaker as one of the top three global players in women's health.
Clinical supplies firm Thermo Fisher Scientific struck a deal to sell its microbiology business to European investment firm Astorg for about $1.08 billion.
The Supreme Court grilled German chemical and pharmaceutical company Bayer over whether it was liable for failing to warn consumers that its flagship weedkiller Roundup might cause cancer, in a case that could wipe out thousands of legal claims if Bayer prevails.
Veradermics' oral version of Rogaine led to "rapid and robust hair growth" for men with pattern hair loss, spurring gains in the recently floated company.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
04-27-26 1704ET
